Cargando…
Ginsenoside and Its Therapeutic Potential for Cognitive Impairment
Cognitive impairment (CI) is one of the major clinical features of many neurodegenerative diseases. It can be aging-related or even appear in non-central nerve system (CNS) diseases. CI has a wide spectrum that ranges from the cognitive complaint with normal screening tests to mild CI and, at its en...
Autores principales: | Feng, Hui, Xue, Mei, Deng, Hao, Cheng, Shiqi, Hu, Yue, Zhou, Chunxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496100/ https://www.ncbi.nlm.nih.gov/pubmed/36139149 http://dx.doi.org/10.3390/biom12091310 |
Ejemplares similares
-
Potential Therapeutic Targets of Quercetin and Its Derivatives: Its Role in the Therapy of Cognitive Impairment
por: Jakaria, Md., et al.
Publicado: (2019) -
Ginsenosides: potential therapeutic source for fibrosis-associated human diseases
por: Li, Xiaobing, et al.
Publicado: (2020) -
Panax ginseng and its ginsenosides: potential candidates for the prevention and treatment of chemotherapy-induced side effects
por: Wan, Yan, et al.
Publicado: (2021) -
Pharmacological potential of ginseng and its major component ginsenosides
por: Ratan, Zubair Ahmed, et al.
Publicado: (2021) -
Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes
por: Bai, Litao, et al.
Publicado: (2018)